Cargando…

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma

Detalles Bibliográficos
Autores principales:	Zeng, Zihang, Gao, Yanping, Li, Jiali, Zhang, Jianguo, Li, Yangyi, He, Fajian, Huang, Zhengrong, Han, Linzhi, Gong, Yan, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201589/ https://www.ncbi.nlm.nih.gov/pubmed/37223520 http://dx.doi.org/10.1016/j.gendis.2022.02.016

Ejemplares similares

SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma
por: Bai, Rui, et al.
Publicado: (2022)

LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
por: Gao, Yanping, et al.
Publicado: (2022)

Additional Postoperative Radiotherapy Prolonged the Survival of Patients with I-IIA Small Cell Lung Cancer: Analysis of the SEER Database
por: Li, Jiali, et al.
Publicado: (2022)

Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis
por: Zeng, Zihang, et al.
Publicado: (2021)

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2021)

Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2022)

Systematic Analyses of a Chemokine Family-Based Risk Model Predicting Clinical Outcome and Immunotherapy Response in Lung Adenocarcinoma
por: Chen, Jiarui, et al.
Publicado: (2021)

SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma
por: Li, Yangyi, et al.
Publicado: (2022)

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis
por: Xu, Liexi, et al.
Publicado: (2022)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

Prediction of radiosensitivity and radiocurability using a novel supervised artificial neural network
por: Zeng, Zihang, et al.
Publicado: (2022)

Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10
por: Yuan, Cheng, et al.
Publicado: (2021)

Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Liu, Xingyu, et al.
Publicado: (2020)

Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis
por: Liu, Xingyu, et al.
Publicado: (2023)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
por: Dai, Weijing, et al.
Publicado: (2022)

Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
por: Li, Jiali, et al.
Publicado: (2020)

Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects
por: Xie, Hongxin, et al.
Publicado: (2022)

Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts
por: Zeng, Zihang, et al.
Publicado: (2022)

Mechanisms and management of 3rd-generation EGFR-TKI resistance in advanced non-small cell lung cancer (Review)
por: He, Jingyi, et al.
Publicado: (2021)

Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma
por: Shi, Hongjie, et al.
Publicado: (2021)

Investigating the functional role of SETD6 in lung adenocarcinoma
por: Xu, Jing, et al.
Publicado: (2023)

Early transcriptomic profiling variation caused by cluster allergen immunotherapy
por: Li, Li-Sha, et al.
Publicado: (2020)

Roles for the methyltransferase SETD8 in DNA damage repair
por: Xu, Libo, et al.
Publicado: (2022)

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer
por: Bai, Rui, et al.
Publicado: (2021)

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer: Retraction
por: Bai, Rui, et al.
Publicado: (2022)

SETD2 maintains nuclear lamina stability to safeguard the genome
por: Khan, Abid, et al.
Publicado: (2023)

Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
por: Lu, Mingdong, et al.
Publicado: (2021)

Roles of SETD2 in Leukemia—Transcription, DNA-Damage, and Beyond
por: Skucha, Anna, et al.
Publicado: (2019)

Establishment of the Prognostic Index Reflecting Tumor Immune Microenvironment of Lung Adenocarcinoma Based on Metabolism-Related Genes
por: Zhang, Jianguo, et al.
Publicado: (2020)

Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway
por: Han, Linzhi, et al.
Publicado: (2022)

Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration
por: AboulFotouh, Khaled, et al.
Publicado: (2021)

IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
por: Yamaki, Toshiaki, et al.
Publicado: (1988)

SETD3 is a positive regulator of DNA-damage-induced apoptosis
por: Abaev-Schneiderman, Elina, et al.
Publicado: (2019)

HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization
por: Sun, Wenjie, et al.
Publicado: (2021)

Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cells
por: Li, Yuanyue, et al.
Publicado: (2012)

Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours
por: Li, Rumeng, et al.
Publicado: (2023)

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
por: Zheng, Xiaobin, et al.
Publicado: (2023)

Epigenotype–genotype–phenotype correlations in SETD1A and SETD2 chromatin disorders
por: Lee, Sunwoo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5brpr77413t0qod1o5fpri3nso